{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:40:03Z","timestamp":1756744803383,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2016-2-2094"],"award-info":[{"award-number":["2016-2-2094"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research on the Application of Capital Clinical the Research on the Application of Capital Clinical Characteristics Program of Beijing Municipal Science and Technology Commission","award":["Z161100000516106"],"award-info":[{"award-number":["Z161100000516106"]}]},{"name":"Key Research and Development Program","award":["2022YFC2705101"],"award-info":[{"award-number":["2022YFC2705101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00467-025-06814-1","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:56:30Z","timestamp":1749182190000},"page":"3219-3231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive genetic analysis and genotype\u2013phenotype correlations in pediatric patients with atypical hemolytic uremic syndrome"],"prefix":"10.1007","volume":"40","author":[{"given":"Jie","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hejia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"6814_CR1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C (2017) Haemolytic uraemic syndrome. Lancet 390:681\u2013696. https:\/\/doi.org\/10.1016\/S0140-6736(17)30062-4","journal-title":"Lancet"},{"key":"6814_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","volume":"91","author":"TH Goodship","year":"2017","unstructured":"Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fremeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodriguez DCS, Roumenina LT, Sethi S, Smith RJ (2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int 91:539\u2013551. https:\/\/doi.org\/10.1016\/j.kint.2016.10.005","journal-title":"Kidney Int"},{"key":"6814_CR3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","volume":"94","author":"F Schaefer","year":"2018","unstructured":"Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommele A, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande WJ, Fremeaux-Bacchi V (2018) Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. Kidney Int 94:408\u2013418. https:\/\/doi.org\/10.1016\/j.kint.2018.02.029","journal-title":"Kidney Int"},{"key":"6814_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschenes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562. https:\/\/doi.org\/10.2215\/CJN.04760512","journal-title":"Clin J Am Soc Nephrol"},{"key":"6814_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2215\/CJN.11470918","volume":"14","author":"G Bayer","year":"2019","unstructured":"Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Merieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM (2019) Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol 14:557\u2013566. https:\/\/doi.org\/10.2215\/CJN.11470918","journal-title":"Clin J Am Soc Nephrol"},{"key":"6814_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.2590","volume":"45","author":"M Lemaire","year":"2013","unstructured":"Lemaire M, Fremeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nurnberg G, Altmuller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nurnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45:531\u2013536. https:\/\/doi.org\/10.1038\/ng.2590","journal-title":"Nat Genet"},{"key":"6814_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa0810739","volume":"361","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 361:345\u2013357. https:\/\/doi.org\/10.1056\/NEJMoa0810739","journal-title":"N Engl J Med"},{"key":"6814_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","volume":"106","author":"M Vivarelli","year":"2024","unstructured":"Vivarelli M, Barratt J, Beck LJ, Fakhouri F, Gale DP, Goicoechea DJE, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith R (2024) The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 106:369\u2013391. https:\/\/doi.org\/10.1016\/j.kint.2024.05.015","journal-title":"Kidney Int"},{"key":"6814_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","volume":"97","author":"AS Levey","year":"2020","unstructured":"Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC (2020) Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 97:1117\u20131129. https:\/\/doi.org\/10.1016\/j.kint.2020.02.010","journal-title":"Kidney Int"},{"key":"6814_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00467-018-4074-4","volume":"34","author":"WY Guo","year":"2019","unstructured":"Guo WY, Song D, Liu XR, Chen Z, Xiao HJ, Ding J, Sun SZ, Liu HY, Wang SX, Yu F, Zhao MH (2019) Immunological features and functional analysis of anti-CFH autoantibodies in patients with atypical hemolytic uremic syndrome. Pediatr Nephrol 34:269\u2013281. https:\/\/doi.org\/10.1007\/s00467-018-4074-4","journal-title":"Pediatr Nephrol"},{"key":"6814_CR11","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1681\/ASN.2018070759","volume":"29","author":"F Bu","year":"2018","unstructured":"Bu F, Zhang Y, Wang K, Borsa NG, Jones MB, Taylor AO, Takanami E, Meyer NC, Frees K, Thomas CP, Nester C, Smith R (2018) Genetic analysis of 400 patients refines understanding and implicates a new gene in atypical hemolytic uremic syndrome. J Am Soc Nephrol 29:2809\u20132819. https:\/\/doi.org\/10.1681\/ASN.2018070759","journal-title":"J Am Soc Nephrol"},{"key":"6814_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1159\/000513009","volume":"145","author":"D Wu","year":"2021","unstructured":"Wu D, Chen J, Ling C, Chen Z, Fan J, Sun Q, Meng Q, Liu X (2021) Clinical and genetic characteristics of atypical hemolytic uremic syndrome in children: a Chinese cohort study. Nephron Clin Pract 145:415\u2013427. https:\/\/doi.org\/10.1159\/000513009","journal-title":"Nephron Clin Pract"},{"key":"6814_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cge.13392","volume":"94","author":"MJ Geerlings","year":"2018","unstructured":"Geerlings MJ, Volokhina EB, de Jong EK, van de Kar N, Pauper M, Hoyng CB, van den Heuvel LP, den Hollander AI (2018) Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration. Clin Genet 94:330\u2013338. https:\/\/doi.org\/10.1111\/cge.13392","journal-title":"Clin Genet"},{"key":"6814_CR14","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2169\/internalmedicine.2713-23","volume":"63","author":"K Osawa","year":"2024","unstructured":"Osawa K, Yamamoto S, Yamano Y, Kita A, Okamoto K, Kato N, Tatematsu Y, Kojima F, Ohya M, Hara S, Murata SI, Inoue N, Maruyama S, Araki SI (2024) Overlapping atypical hemolytic uremic syndrome and C3 glomerulopathy with mutation in CFI in a Japanese patient: a case report. Intern Med 63:1777\u20131782. https:\/\/doi.org\/10.2169\/internalmedicine.2713-23","journal-title":"Intern Med"},{"key":"6814_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ped.12549","volume":"57","author":"JM Lee","year":"2015","unstructured":"Lee JM, Park YS, Lee JH, Park SJ, Shin JI, Park YH, Yoo KH, Cho MH, Kim SY, Kim SH, Namgoong MK, Lee SJ, Lee JH, Cho HY, Han KH, Kang HG, Ha IS, Bae JS, Kim NK, Park WY, Cheong HI (2015) Atypical hemolytic uremic syndrome: Korean pediatric series. Pediatr Int 57:431\u2013438. https:\/\/doi.org\/10.1111\/ped.12549","journal-title":"Pediatr Int"},{"key":"6814_CR16","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1182\/blood.2022018833","volume":"142","author":"V Brocklebank","year":"2023","unstructured":"Brocklebank V, Walsh PR, Smith-Jackson K, Hallam TM, Marchbank KJ, Wilson V, Bigirumurame T, Dutt T, Montgomery EK, Malina M, Wong E, Johnson S, Sheerin NS, Kavanagh D (2023) Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study. Blood 142:1371\u20131386. https:\/\/doi.org\/10.1182\/blood.2022018833","journal-title":"Blood"},{"key":"6814_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fimmu.2019.01282","volume":"10","author":"M Puraswani","year":"2019","unstructured":"Puraswani M, Khandelwal P, Saini H, Saini S, Gurjar BS, Sinha A, Shende RP, Maiti TK, Singh AK, Kanga U, Ali U, Agarwal I, Anand K, Prasad N, Rajendran P, Sinha R, Vasudevan A, Saxena A, Agarwal S, Hari P, Sahu A, Rath S, Bagga A (2019) Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database. Front Immunol 10:1282. https:\/\/doi.org\/10.3389\/fimmu.2019.01282","journal-title":"Front Immunol"},{"key":"6814_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","volume":"34","author":"C Formeck","year":"2019","unstructured":"Formeck C, Swiatecka-Urban A (2019) Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol 34:1337\u20131348. https:\/\/doi.org\/10.1007\/s00467-018-4039-7","journal-title":"Pediatr Nephrol"},{"key":"6814_CR19","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","volume":"29","author":"S Johnson","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM (2014) An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol 29:1967\u20131978. https:\/\/doi.org\/10.1007\/s00467-014-2817-4","journal-title":"Pediatr Nephrol"},{"key":"6814_CR20","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859. https:\/\/doi.org\/10.2215\/CJN.02210310","journal-title":"Clin J Am Soc Nephrol"},{"key":"6814_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","volume":"27","author":"LM Geerdink","year":"2012","unstructured":"Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Komhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC (2012) Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27:1283\u20131291. https:\/\/doi.org\/10.1007\/s00467-012-2131-y","journal-title":"Pediatr Nephrol"},{"key":"6814_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s10157-018-1549-3","volume":"22","author":"M Fujisawa","year":"2018","unstructured":"Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M (2018) Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome. Clin Exp Nephrol 22:1088\u20131099. https:\/\/doi.org\/10.1007\/s10157-018-1549-3","journal-title":"Clin Exp Nephrol"},{"key":"6814_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ki.2013.373","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Gulati A, Saini S, Blanc C, Gupta A, Gurjar BS, Saini H, Kotresh ST, Ali U, Bhatia D, Ohri A, Kumar M, Agarwal I, Gulati S, Anand K, Vijayakumar M, Sinha R, Sethi S, Salmona M, George A, Bal V, Singh G, Dinda AK, Hari P, Rath S, Dragon-Durey MA, Bagga A (2014) Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children. Kidney Int 85:1151\u20131160. https:\/\/doi.org\/10.1038\/ki.2013.373","journal-title":"Kidney Int"},{"key":"6814_CR24","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2014010096","volume":"26","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM, Shi SF, Liu LJ, Yu F, Zhao MH, Novak J, Gharavi AG, Zhang H (2015) Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol 26:1195\u20131204. https:\/\/doi.org\/10.1681\/ASN.2014010096","journal-title":"J Am Soc Nephrol"},{"key":"6814_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","volume":"17","author":"F Fakhouri","year":"2021","unstructured":"Fakhouri F, Fremeaux-Bacchi V (2021) Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics. Nat Rev Nephrol 17:543\u2013553. https:\/\/doi.org\/10.1038\/s41581-021-00424-4","journal-title":"Nat Rev Nephrol"},{"key":"6814_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2215\/CJN.01260212","volume":"8","author":"J Hofer","year":"2013","unstructured":"Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Wurzner R, Jungraithmayr T (2013) Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 8:407\u2013415. https:\/\/doi.org\/10.2215\/CJN.01260212","journal-title":"Clin J Am Soc Nephrol"},{"key":"6814_CR27","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1093\/ndt\/gfq010","volume":"25","author":"D Westra","year":"2010","unstructured":"Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L (2010) Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS). Nephrol Dial Transplant 25:2195\u20132202. https:\/\/doi.org\/10.1093\/ndt\/gfq010","journal-title":"Nephrol Dial Transplant"},{"key":"6814_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","volume":"115","author":"I Moore","year":"2010","unstructured":"Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ (2010) Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood 115:379\u2013387. https:\/\/doi.org\/10.1182\/blood-2009-05-221549","journal-title":"Blood"},{"key":"6814_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molimm.2015.06.021","volume":"67","author":"ME Bernabeu-Herrero","year":"2015","unstructured":"Bernabeu-Herrero ME, Jimenez-Alcazar M, Anter J, Pinto S, Sanchez CD, Garrido S, Lopez-Trascasa M, Rodriguez DCS, Sanchez-Corral P (2015) Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome. Mol Immunol 67:276\u2013286. https:\/\/doi.org\/10.1016\/j.molimm.2015.06.021","journal-title":"Mol Immunol"},{"key":"6814_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2016.99","volume":"12","author":"MA Durey","year":"2016","unstructured":"Durey MA, Sinha A, Togarsimalemath SK, Bagga A (2016) Anti-complement-factor H-associated glomerulopathies. Nat Rev Nephrol 12:563\u2013578. https:\/\/doi.org\/10.1038\/nrneph.2016.99","journal-title":"Nat Rev Nephrol"},{"key":"6814_CR31","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s00467-022-05862-1","volume":"38","author":"P Khandelwal","year":"2023","unstructured":"Khandelwal P, Joshi A, Mathur A, Puraswani M, Gurjar BS, Sinha A, Hari P, Faruq M, Bagga A (2023) Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome. Pediatr Nephrol 38:2659\u20132668. https:\/\/doi.org\/10.1007\/s00467-022-05862-1","journal-title":"Pediatr Nephrol"},{"key":"6814_CR32","doi-asserted-by":"publisher","first-page":"1011580","DOI":"10.3389\/fimmu.2022.1011580","volume":"13","author":"R Piras","year":"2022","unstructured":"Piras R, Valoti E, Alberti M, Bresin E, Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, Remuzzi G, Noris M (2022) CFH and CFHR structural variants in atypical hemolytic uremic syndrome: prevalence, genomic characterization and impact on outcome. Front Immunol 13:1011580. https:\/\/doi.org\/10.3389\/fimmu.2022.1011580","journal-title":"Front Immunol"},{"key":"6814_CR33","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1182\/blood.2021012037","volume":"138","author":"MH Martin","year":"2021","unstructured":"Martin MH, Zhang Y, Arjona E, Del AG, Goodfellow R, Gomez-Rubio E, Ji RR, Michelena M, Smith R, Rodriguez DCS (2021) Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification. Blood 138:2185\u20132201. https:\/\/doi.org\/10.1182\/blood.2021012037","journal-title":"Blood"},{"key":"6814_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nchembio.1696","volume":"11","author":"BS Blaum","year":"2015","unstructured":"Blaum BS, Hannan JP, Herbert AP, Kavanagh D, Uhrin D, Stehle T (2015) Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat Chem Biol 11:77\u201382. https:\/\/doi.org\/10.1038\/nchembio.1696","journal-title":"Nat Chem Biol"},{"key":"6814_CR35","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1182\/blood-2015-11-680009","volume":"127","author":"S Hyvarinen","year":"2016","unstructured":"Hyvarinen S, Meri S, Jokiranta TS (2016) Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome. Blood 127:2701\u20132710. https:\/\/doi.org\/10.1182\/blood-2015-11-680009","journal-title":"Blood"},{"key":"6814_CR36","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.4049\/jimmunol.177.9.6308","volume":"177","author":"VP Ferreira","year":"2006","unstructured":"Ferreira VP, Herbert AP, Hocking HG, Barlow PN, Pangburn MK (2006) Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol 177:6308\u20136316. https:\/\/doi.org\/10.4049\/jimmunol.177.9.6308","journal-title":"J Immunol"},{"key":"6814_CR37","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","volume":"31","author":"TK Maga","year":"2010","unstructured":"Maga TK, Nishimura CJ, Weaver AE, Frees KL, Smith RJ (2010) Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat 31:E1445\u2013E1460. https:\/\/doi.org\/10.1002\/humu.21256","journal-title":"Hum Mutat"},{"key":"6814_CR38","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","volume":"125","author":"EC Schramm","year":"2015","unstructured":"Schramm EC, Roumenina LT, Rybkine T, Chauvet S, Vieira-Martins P, Hue C, Maga T, Valoti E, Wilson V, Jokiranta S, Smith RJ, Noris M, Goodship T, Atkinson JP, Fremeaux-Bacchi V (2015) Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood 125:2359\u20132369. https:\/\/doi.org\/10.1182\/blood-2014-10-609073","journal-title":"Blood"},{"key":"6814_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","volume":"24","author":"E Bresin","year":"2013","unstructured":"Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez DCS, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M (2013) Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 24:475\u2013486. https:\/\/doi.org\/10.1681\/ASN.2012090884","journal-title":"J Am Soc Nephrol"},{"key":"6814_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ki.2009.472","volume":"77","author":"F Bienaime","year":"2010","unstructured":"Bienaime F, Dragon-Durey MA, Regnier CH, Nilsson SC, Kwan WH, Blouin J, Jablonski M, Renault N, Rameix-Welti MA, Loirat C, Sautes-Fridman C, Villoutreix BO, Blom AM, Fremeaux-Bacchi V (2010) Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Int 77:339\u2013349. https:\/\/doi.org\/10.1038\/ki.2009.472","journal-title":"Kidney Int"},{"key":"6814_CR41","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1182\/blood.2020006931","volume":"136","author":"E Arjona","year":"2020","unstructured":"Arjona E, Huerta A, Goicoechea DJE, Rodriguez DCS (2020) Familial risk of developing atypical hemolytic-uremic syndrome. Blood 136:1558\u20131561. https:\/\/doi.org\/10.1182\/blood.2020006931","journal-title":"Blood"},{"key":"6814_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3389\/fimmu.2019.00853","volume":"10","author":"E Valoti","year":"2019","unstructured":"Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M (2019) Rare functional variants in complement genes and anti-FH autoantibodies-associated aHUS. Front Immunol 10:853. https:\/\/doi.org\/10.3389\/fimmu.2019.00853","journal-title":"Front Immunol"},{"key":"6814_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.thromres.2020.06.016","volume":"194","author":"JW Yun","year":"2020","unstructured":"Yun JW, Oh J, Lee K, Lee SJ, Kim JO, Kim NK, Kim JS, Koh Y, Yoon S, Yhim H, Jo S, Park Y, Lee JE, Park J, Lee JW, Kim S, Kim H, Oh D (2020) Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome. Thromb Res 194:45\u201353. https:\/\/doi.org\/10.1016\/j.thromres.2020.06.016","journal-title":"Thromb Res"},{"key":"6814_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, Marquez-Tirado B, Goicoechea De Jorge E (2023) The factor H protein family: the switchers of the complement alternative pathway. Immunol Rev 313:25\u201345. https:\/\/doi.org\/10.1111\/imr.13166","journal-title":"Immunol Rev"},{"key":"6814_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12185-014-1655-2","volume":"100","author":"T Matsumoto","year":"2014","unstructured":"Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T (2014) Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p. I1157T mutation. Int J Hematol 100:437\u2013442. https:\/\/doi.org\/10.1007\/s12185-014-1655-2","journal-title":"Int J Hematol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06814-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:04:36Z","timestamp":1756742676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06814-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["6814"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06814-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Beijing Children\u2019s Hospital, Capital Medical University. All procedures performed in our studies were in accordance with these ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}